News

Pharma Cluster Accelerator Announces New Diversity, Equity and Inclusion Lead

New position ensures access to opportunities created by the Advanced Pharmaceutical Research and Manufacturing Cluster regardless of race, ethnicity, gender, or geographic location.

Richmond, VA –  The Cluster Accelerator for Advanced Pharmaceutical Research and Manufacturing, an entity launched to fast-track the development of a globally competitive essential medicines manufacturing hub across Central Virginia, announced the hiring of Vanessa Womack as its lead for Diversity, Equity and Inclusion. The new position will oversee efforts to ensure the diverse rural-urban community that comprises the Greater Richmond-Petersburg MSA can participate in opportunities created by the emerging Advanced Pharmaceutical Research and Manufacturing industry.

Jeff Gallagher, interim Executive Director of the Cluster Accelerator said, “We are excited to have Ms. Womack as part of our team and we will lean on her expertise in diversity, equity and inclusion, to help us craft and execute on a strategy to support these efforts in life sciences. We are building a global industry and we are scaling up quickly, and the selection of Vanessa will ensure the opportunities and benefits of this emerging industry extend to the diverse population in the region.” The Central Virginia region is diverse, covering five cities and twelve counties with both urban and rural populations.

The New Diversity, Equity and Inclusion Lead role will be responsible for driving a region-wide diversity, equity and inclusion strategy, and will coordinate and implement regional efforts to support an inclusive culture for life sciences, focusing initially on the DEI plan component of the Build Back Better Regional Competition grant award from the US Economic Development Administration (EDA). Working collaboratively with public and private sector organizations, Ms. Womack will design and execute the strategy to engage the community training, employment and supplier for life sciences and act as an important community liaison.

Prior to this role, Ms. Womack served as Programs, Training and Technical Assistance Planner at the Virginia Community Healthcare Association for nearly nine years developing strategic training programming and advancing efforts to grow an educational resource for healthcare leaders. She also has significant experience in DEI initiatives through her consulting company, Vanessa Womack Consulting, working with organizations on managing diverse teams, improving organizational culture, and board training.

The Advanced Pharmaceutical Manufacturing and Research & Development (R&D) Cluster Accelerator is built upon regional research, innovation and manufacturing assets with a goal of building a world-class hub to research and manufacture essential medicines for Americans by leveraging our competitive assets.

The regional cluster accelerator’s goal is to help build a globally competitive pharmaceutical manufacturing and R&D industry in the Central Virginia region. The work will fast-track regional efforts to reshore and secure the production of essential medicines in the United States, lower their costs and ensure access to quality medicines in the U.S. and around the world. Many organizations will support scale-up in infrastructure, workforce development, and supply chain development.

Read more here.

Recent News

05/13/2026

BRAINBox Solutions Announces Appointment of Richard H. Noel as Chief Product and Commercial Officer

BRAINBox Solutions today announced the appointment of Richard H. Noel to the newly created position of Chief Product and Commercial Officer. Richard brings more than 10 years of experience in molecular and point-of-care diagnostics, at Roche Diagnostics, LumiraDx, and bioMérieux. “Richard, whose expertise spans market analytics, global product management, and senior commercial leadership, has established

05/12/2026

Phlow Corp. Appoints Tim Mayleben Chief Executive Officer as Co-Founder Dr. Eric Edwards Transitions to Chairman Emeritus and Strategic Advisor

Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Tim Mayleben has been appointed Chief Executive Officer, effective immediately. Eric Edwards, M.D., Ph.D., Phlow’s co-founder and former CEO, has transitioned to the role of Chairman Emeritus and Strategic Advisor to the CEO and Board of Directors. The leadership

05/09/2026

NIRSense Supports the US Army in the Indo-Pacific with Tissue Oxygenation Assessment for Battlefield Casualty Care at Balikatan-26

NIRSense, Inc. today announced its participation in Balikatan-26, supporting the US Army Pacific (USARPAC)’s 18th Theater Medical Command (18th TMC) as they evaluate advanced approaches to battlefield casualty assessment using portable tissue oxygen saturation (StO₂) monitoring. Balikatan, meaning “shoulder-to-shoulder,” is the longstanding U.S.-Philippine bilateral exercise designed to strengthen interoperability and regional readiness through combined operations